Key result
Heartwatch secondary prevention program linked to improved BP, cholesterol, and smoking status over two years.
Why the study?
Does the Heartwatch secondary prevention programme improve cardiovascular risk factors and treatments in patients with established CHD?
Population
11,542 patients with established CHD in primary care in Ireland
Comparison
Heartwatch secondary prevention programme in… vs Baseline (pre-intervention)
Design
Cohort
Follow-up
2 years
Authors
Loading...
Supports primary care secondary prevention programs; leaves open causal outcome benefits pending randomized trials.
Cohort (n=11,542)
Yes
Does the Heartwatch secondary prevention programme improve cardiovascular risk factors and treatments in patients with established CHD?
p-value: p=<0.0001
A nationwide secondary prevention program in primary care significantly improved blood pressure, lipid profiles, smoking cessation, and guideline-directed medical therapy uptake in patients with established CHD.
Bennett et al. (2008) conducted a cohort in Coronary heart disease (CHD) (n=11,542). Heartwatch programme vs. Baseline was evaluated on Changes in cardiovascular risk factors and treatments (p=<0.0001). The Heartwatch secondary prevention programme was associated with statistically significant improvements in blood pressure, cholesterol, and smoking status at 1 and 2 years (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: